Company & Sponsor Intelligence
University of Maryland, College Park
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed3
Countries1
Therapeutic footprint
adhdepilepsy
Indexed studies
NCT01065597Nonconvulsive Electrotherapy: a Proof-of-concept Trial
epilepsy · United StatesPHASE1
epilepsy · United StatesPHASE1
NCT00316290Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder
adhd · United StatesNA
adhd · United StatesNA
NCT00318981Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
adhd · United StatesPHASE4
adhd · United StatesPHASE4
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →